Tertiary Lymphoid Structures as Independent Predictors of Favorable Prognosis in Muscle‐Invasive Bladder Cancer
Cancer Medicine · 2025-05 · 14 (10)
DOI: 10.1002/cam4.70978 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 21.05.2025. Verfasst von Xiaodong Teng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Tertiary Lymphoid Structures. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China, Zhejiang Provincial Research Center for Cancer Intelligent Diagnosis and Molecular Technology, Zhejiang Provincial Outstanding Youth Science Foundation.
Abstract (Originalsprache)
Background
Tertiary lymphoid structure (TLS) has been reported to be associated with prognosis and immunotherapy in certain cancers. The objective of our study was to investigate the prognostic significance of Tertiary Lymphoid Structures (TLS) within the context of Muscle‐Invasive Bladder Cancer (MIBC), while concurrently examining the clinicopathological and molecular determinants influencing TLS formation.
Methods
Immunohistochemistry was used to detect the expression of TLS, CD8+ T cells, B cells, and plasma cells in 119 MIBC cases, of which 80 cases were tested by next generation sequencing (NGS) for analyzing the differences in gene alterations between TLS‐negative and TLS‐positive.
Results
TLS were identified in 52.1% (62/119) of the MIBC cases studied. Patients exhibiting TLS demonstrated reduced T and TNM staging and prolonged overall survival (OS) compared to those lacking TLS. Multivariate analysis showed that TLS was an independent prognostic factor. Densities of B cells, CD8+ T cells, and plasma cells in tumors were significantly correlated with TLS, but in the cases with low‐density B cells, high‐density CD8+ T cells, or high‐density plasma cells, differences in OS between the tumors with TLS and without TLS were not significant. Compared with TLS‐negative tumors, TLS‐positive tumors had a lower frequency of TP53 mutations and higher frequencies of FAT1 and CDKN1A mutations. Tumor mutational burden (TMB) was not significantly different between the two groups but was significantly associated with TLS in TP53 wild‐type tumors.
Conclusions
TLS emerged as an independent harbinger of favorable prognosis in MIBC, predominantly mediating antitumor responses via B cells. Moreover, TP53 mutations were identified as a potential inhibitor of TLS formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China.
ORCID-Profile: Xiaodong Teng
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- Zhejiang Provincial Research Center for Cancer Intelligent Diagnosis and Molecular Technology
- Zhejiang Provincial Outstanding Youth Science Foundation
Zitieren
APA
Teng, X., Chen, Z., Bai, Y., Cao, H., Zhang, J., Xu, L., Liu, K., Shi, Y., & Shao, Y. (2025). Tertiary Lymphoid Structures as Independent Predictors of Favorable Prognosis in Muscle‐Invasive Bladder Cancer. Cancer Medicine, 14(10). https://doi.org/10.1002/cam4.70978
Vancouver
Teng X, Chen Z, Bai Y, Cao H, Zhang J, Xu L, et al. Tertiary Lymphoid Structures as Independent Predictors of Favorable Prognosis in Muscle‐Invasive Bladder Cancer. Cancer Medicine. 2025;14(10). doi:10.1002/cam4.70978
BibTeX
@article{Teng2025,
author = {Teng, Xiaodong and Chen, Zhen and Bai, Yanfeng and Cao, Hui and Zhang, Jing and Xu, Liming and Liu, Kaihua and Shi, Yuqian and Shao, Yang},
title = {Tertiary Lymphoid Structures as Independent Predictors of Favorable Prognosis in Muscle‐Invasive Bladder Cancer},
journal = {Cancer Medicine},
year = {2025},
volume = {14},
number = {10},
doi = {10.1002/cam4.70978}
}
EUVIMED